Results for “ ”

Entry Author Date Location
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial 11/12/19 Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange 11/11/19 San Francisco
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test 11/07/19 Boston
Arkuda Unveils $44M and a Protein Restoration Approach to Dementia 11/07/19 Boston
3 Changes We Should Make to Address the Gender Pay Gap in Medicine 11/06/19 Boston
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund 11/06/19 National
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis 11/06/19 Boston
GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site 11/06/19 National
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32 11/05/19 San Diego
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases 10/31/19 Boston
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug 10/31/19 Boston
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Disc Medicine Launches With $50M to Advance New Anemia Treatments 10/29/19 Boston
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Former Quartet, Knewton Exec David Liu Joins Sonde Health as CEO 10/24/19 Boston
Xconomy Awards Boston 2019 Honors Best in Life Sciences: Slideshow 10/23/19 Boston
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing 10/22/19 Boston
Vertex Stock Up on Quick FDA OK For 3-Drug Cystic Fibrosis Therapy 10/22/19 Boston
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer 10/21/19 Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs 10/17/19 National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices 10/17/19 Boston
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms 10/16/19 Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades 10/11/19 Indiana
Page 1 of 626 next page »